Chips and Bears in the Spotlight
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Options markets are flashing mixed signals this week. Earnings risk and macro uncertainty are driving unusual positioning across tech and logistics names.
MU heads into its Tuesday print with the most crowded options setup in the sector. The chipmaker has 23 active expiry dates stacked through September. Its ORTEX momentum score hit 91.4 — a five-week high. The stock is up 200% from its April low. That kind of run attracts both momentum chasers and hedgers. Short interest sits at just 3.3% of free float. Puts here look like pure earnings insurance.
Bears are louder on IOT, the fleet-intelligence firm Samsara. Short interest stands at 11.9% of free float — nearly four times Micron's level. Options chains run to September. With a June earnings print approaching, the put-side buildup fits the short seller narrative already established in the stock.
NVDA carries a $5.1 trillion market cap and just 1.3% short interest. Its expiry ladder runs to September 18. ORTEX reports three analyst notes flagging quality intact but price lagging peers. That tension — strong fundamentals, soft relative price — often sparks late call-side sweeps before momentum reasserts.
FDX reports this week too. Short interest is light at 1.7% of free float. Options thin out quickly beyond July. The macro backdrop matters here: a hawkish Fed shift is hitting global currency bets. That could weigh on FedEx's international volumes and draw defensive put buyers into the June 26 expiry.
Watch the June 26 expiry across all four names. That's where earnings risk and macro uncertainty collide.
This is not financial advice.
Stocks in this article
How this article was generated
- Generated
- 21 Jun 2026, 04:47
- Prompt version
- v1.0
- Data sources
- Options flowORTEX Alpha signals
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.